Sanofi Bets on mRNA Vaccines After Covid-19 Pandemic Shows Worth

Sanofi, one of the world’s biggest vaccine makers, plans to invest some $477 million a year to catch up in the new gene-based technology.

Gores Guggenheim SPAC Nears Deal to Combine With Polestar

Polestar is nearing a deal to go public through a merger...

U.S.-EU Trade Summit in Pittsburgh Aims to Deepen Trans-Atlantic Ties

Senior European Union officials including Margrethe Vestager will meet with U.S....

China Has New Way to Fight IP Theft Claims

Chinese technology giants have seized on a new legal tactic to...

Economy Week Ahead: Consumer Spending, Inflation, Manufacturing

Markets this week will be focusing on U.S. consumer spending and...